Diabetes
Insulin in Focus
Insulin in Focus is a series of episodes featuring expert discussions on current topics related to the benefits and practical considerations of using insulin in the management of type 2 diabetes.
This module explores the role of insulin and where it fits in the broader type 2 diabetes management journey.
- For some patients, non-insulin therapies may not be enough to maintain glycemic control.
- Insulin initiation and optimization can play an important role when clinically appropriate.
- Care teams help support long-term success through individualized treatment approaches.
This module examines the impact of therapeutic inertia and the patient, provider, and systemic factors that can contribute to treatment delays.
- Therapeutic inertia is a common challenge in type 2 diabetes management.
- Delays in treatment escalation can lead to prolonged hyperglycemia.
- Proactive conversations support timely treatment decisions.
This module outlines strategies to help patients recognize and manage hypoglycemia while living with type 2 diabetes.
- Recognizing hypoglycemia early is critical to effective patient care.
- Implementing practical strategies may help patients respond with confidence.
- Proactive counseling can protect patients against severe hypoglycemic events.
This module discusses the factors behind insulin initiation and provides a patient discussion guide.
- There are a range of practical and emotional barriers that can impact insulin initiation.
- Early education and support can help address common misconceptions.
- A proactive counseling checklist may help reduce patient hesitation.
Find more information
Speak to a medical representative
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
Novo Nordisk Medical is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
